Enfuvirtide, an HIV-1 fusion inhibitor.
Andrew
A
Carr
D000327:Adsorption; D019380:Anti-HIV Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000077560:Enfuvirtide; D015700:HIV Envelope Protein gp41 / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D007279:Injections, Subcutaneous / Q000009:adverse effects*; D010349:Patient Compliance; D010446:Peptide Fragments / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D017211:Treatment Failure
D019380:Anti-HIV Agents; D015700:HIV Envelope Protein gp41; D010446:Peptide Fragments; D012367:RNA, Viral; D000077560:Enfuvirtide